A phone, a pocket, a short walk. OneStep turns an ordinary routine into mobility data - and asks what healthcare misses between appointments.
A clinical trial can change its doses, its cohorts, and its countries. Cenduit, now IQVIA IRT, handles the less glamorous question that follows: which medicine goes to which patient next?
The Maryland company learned that FDA clearance was only the opening move. Its more durable play is connecting devices, care teams and everyday decisions - then selling that regulated intelligence through the institutions already paying for chronic care.
Most MRI scans show anatomy. BrainSpec reads the chemical signals hiding in the same machine - and turns an expert-only technique into a report designed for clinical use.